Direkt zum Inhalt
Merck

SAB4200143

Sigma-Aldrich

Anti-ADAR2 antibody, Mouse monoclonal

clone ADAR2-15, purified from hybridoma cell culture

Synonym(e):

Anti-ADARB1, Anti-Adenosine Deaminase, RNA-specific B1, Anti-DRABA2, Anti-DRADA2, Anti-RED1, Anti-RNA Editase 1, Anti-RNA-editing enzyme 1

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

MDL-Nummer:
UNSPSC-Code:
12352203
NACRES:
NA.41

Biologische Quelle

mouse

Konjugat

unconjugated

Antikörperform

purified from hybridoma cell culture

Antikörper-Produkttyp

primary antibodies

Klon

ADAR2-15, monoclonal

Form

buffered aqueous solution

Mol-Gew.

antigen ~130 kDa

Speziesreaktivität

human

Methode(n)

western blot: 1:250-1:500 using HEK-293T cells overexpressing ADAR2 (a working dilution)

Isotyp

IgG

Versandbedingung

dry ice

Lagertemp.

−20°C

Posttranslationale Modifikation Target

unmodified

Angaben zum Gen

human ... ADAR2(104)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

Adenosine deaminase acting on RNA type 2 (ADAR2), also known as adenosine deaminase, RNA specific B1 (ADARB1), is encoded by the gene mapped to human chromosome 21q22.3. ADARB1 is characterized with two double-stranded RNA-binding domains and a deaminase domain involved in editing action.
Monoclonal Anti-ADAR2 (mouse IgG2a isotype) is derived from the hybridoma ADAR2-15 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a synthetic peptide corresponding to a fragment of human ADAR2, conjugated to KLH. Adenosine deaminase acting on RNA type 2 is expressed mainly in nucleus.

Spezifität

Monoclonal Anti-ADAR2 recognizes human ADAR2

Anwendung

Monoclonal Anti-ADAR2 antibody produced in mouse may be used in several immunochemical techniques including immunoblotting.

Biochem./physiol. Wirkung

Adenosine deaminase acting on RNA type 2 (ADAR2) enzyme plays a vital role in editing pre-mRNA of glutamate receptor B subunit. Combined effect of ADAR2 and HTR2C (5-hydroxytryptamine receptor 2C) variants contribute to the suicide attempt (SA) vulnerability in psychiatric patients. ADAR2 is a candidate gene for neurological diseases, such as bipolar affective disorder and epilepsy. Decrease in the activity of ADAR2 enzyme results in α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor-mediated death of motor neurons in mice. ADAR2 enzyme is expressed consistently in carcinomas and sarcomas and it is upregulated in lymphomas and seminomas when compared to normal tissues.

Physikalische Form

Solution in 0.01M phosphate buffered saline pH 7.4, containing 15 mM sodium azide and horse immunoglobulins

Lagerung und Haltbarkeit

Store at −20 °C. For continuous use, store at 2–8 °C for up to one month. For extended storage, freeze at −20 °C in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers, is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.

Haftungsausschluss

Unless otherwise stated in our catalog, our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sie haben nicht das passende Produkt gefunden?  

Probieren Sie unser Produkt-Auswahlhilfe. aus.

Lagerklassenschlüssel

12 - Non Combustible Liquids

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

SUMO-1 modification alters ADAR1 editing activity
Desterro JMP
Molecular Biology of the Cell, 16(11), 5115-5126 (2005)
Sequence analysis of ADARB1 gene in patients with familial bipolar disorder.
Amore M
Journal of Affective Disorders, 81, 79-85 (2004)
Joint effect of ADARB1 gene, HTR2C gene and stressful life events on suicide attempt risk in patients with major psychiatric disorders.
Karanovic J
The World Journal of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry, 16, 261-271 (2015)
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets.
Flanagan JM
Molecular Cancer Therapeutics, 8, 249-260 (2009)
Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2
J Neurosci
The Journal of Neuroscience, 30, 11917-11925 (2010)

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.